Glaxosmithkline

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Glaxo names new CEO to succeed Andrew Witty

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Business By Rebecca Robbins

A popular weight-loss pill was buoyed by studies that understated its harms

Pharmalot By Ed Silverman

Novartis execs in Korea are indicted for bribing doctors

Pharmalot By Ed Silverman

Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’

Business By Stephanie Simon

Google spinoff teams with pharma giant to treat disease by zapping nerves

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK

Pharmalot By Ed Silverman

FDA sends stern warning to Glaxo over contamination at a penicillin plant

Pharmalot By Ed Silverman

Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: France opens criminal probe into clinical trial

Pharmalot By Ed Silverman

Supreme Court says Glaxo must face racketeering lawsuits over a diabetes pill

Pharmalot By Ed Silverman

Most scientists believe there is a ‘crisis’ reproducing experiments

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Feds probe Sun Pharma over generic pricing

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Pfizer syphilis treatment in short supply

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pharmalot By Ed Silverman

Most Read

Up and down the ladder: The latest comings and goings

Corporate private eyes accuse Glaxo of taking actions that led to their imprisonment

Which drug makers do a good job getting poor patients access to their medicines?

Pharmalot, Pharmalittle: Glaxo CEO looks for drug prices to fall no matter who is president

Supreme Court lets pay-to-delay ruling against pharma stand

What clinical trial results? Now you can see who isn’t sharing their findings

Glaxo to pay $20 million for bribing doctors in China

Up and down the ladder: The latest comings and goings

All Coverage

Pharmalot, Pharmalittle: Glaxo names new CEO to succeed Andrew Witty

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

A popular weight-loss pill was buoyed by studies that understated its harms

Novartis execs in Korea are indicted for bribing doctors

Q&A: Glaxo exec says bioelectronics venture with Verily is ‘not science fiction’

Google spinoff teams with pharma giant to treat disease by zapping nerves

Pharmalot, Pharmalittle: Brexit, schmexit. Glaxo invests $360 million in the UK

FDA sends stern warning to Glaxo over contamination at a penicillin plant

Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents

Pharmalot, Pharmalittle: France opens criminal probe into clinical trial

Supreme Court says Glaxo must face racketeering lawsuits over a diabetes pill

Most scientists believe there is a ‘crisis’ reproducing experiments

Pharmalot, Pharmalittle: Feds probe Sun Pharma over generic pricing

Pharmalot, Pharmalittle: Pfizer syphilis treatment in short supply

Up and down the ladder: The latest comings and goings

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pharmalot, Pharmalittle: Glaxo may have to boost pay for its next CEO

Subscribe to STAT for $15 per month lorem ipsum

GlaxoSmithKline

Most Read

All Coverage

Subscribe to STAT for $15 per month lorem ipsum